Residual structure and dynamics in Parkinson's disease-associated mutants of α-synuclein

被引:212
作者
Bussell, R
Eliezer, D
机构
[1] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Program Struct Biol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Dept Physiol Biophys & Mol Med, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.M106777200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha -Synuclein (alphaS) is a pre-synaptic protein that has been implicated as a possible causative agent in the pathogenesis of Parkinson's disease (PD). Two autosomal dominant missense mutations in the aS gene are associated with early onset PD. Because aS is found in an aggregated fibrillar form in the Lewy body deposits characteristic of Parkinson's patients, aggregation of the protein is believed to be related to its involvement in the disease process. The wild type (WT) and early onset mutants A30P and A53T display diverse in vitro aggregation kinetics even though the gross physicochemical and morphological properties of the mutants are highly similar. We used high resolution solution NMR spectroscopy to compare the structural and dynamic properties of the A53T and A30P mutants with those of WT aS in the free state. We found that the A30P mutation disrupts a region of residual helical structure that exists in the WT protein, whereas the A53T mutation results in a slight enhancement of a small region around the site of mutation with a preference for extended conformations. Based on these results and on the anticipated effects of these mutations on elements of secondary structure, we proposed a model of how these two PD-linked mutations influence aS fibril formation that is consistent with the documented differences in the fibrillization kinetics of the two mutants.
引用
收藏
页码:45996 / 46003
页数:8
相关论文
共 55 条
[21]   Parkinson's disease and other α-synucleinopathies [J].
Goedert, M .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (04) :308-312
[22]   THE CORE ALZHEIMERS PEPTIDE NAC FORMS AMYLOID FIBRILS WHICH SEED AND ARE SEEDED BY BETA-AMYLOID - IS NAC A COMMON TRIGGER OR TARGET IN NEURODEGENERATIVE DISEASE [J].
HAN, HY ;
WEINREB, PH ;
LANSBURY, PT .
CHEMISTRY & BIOLOGY, 1995, 2 (03) :163-169
[23]   NON-A-BETA COMPONENT OF ALZHEIMERS-DISEASE AMYLOID (NAC) IS AMYLOIDOGENIC [J].
IWAI, A ;
YOSHIMOTO, M ;
MASLIAH, E ;
SAITOH, T .
BIOCHEMISTRY, 1995, 34 (32) :10139-10145
[24]   Regulation of phospholipase D2:: Selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins [J].
Jenco, JM ;
Rawlingson, A ;
Daniels, B ;
Morris, AJ .
BIOCHEMISTRY, 1998, 37 (14) :4901-4909
[25]   Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation [J].
Jensen, PH ;
Nielsen, MS ;
Jakes, R ;
Dotti, G ;
Goedert, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26292-26294
[26]   Binding of A beta to alpha- and beta-synucleins: Identification of segments in alpha-synuclein/NAC precursor that bind A beta and NAC [J].
Jensen, PH ;
Hojrup, P ;
Hager, H ;
Nielsen, MS ;
Jacobsen, L ;
Olesen, OF ;
Gliemann, J ;
Jakes, R .
BIOCHEMICAL JOURNAL, 1997, 323 :539-546
[27]   NMR VIEW - A COMPUTER-PROGRAM FOR THE VISUALIZATION AND ANALYSIS OF NMR DATA [J].
JOHNSON, BA ;
BLEVINS, RA .
JOURNAL OF BIOMOLECULAR NMR, 1994, 4 (05) :603-614
[28]   Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].
Krüger, R ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Graeber, M ;
Kösel, S ;
Przuntek, H ;
Epplen, JT ;
Schöls, L ;
Riess, O .
NATURE GENETICS, 1998, 18 (02) :106-108
[29]   Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders [J].
Krüger, R ;
Müller, T ;
Riess, O .
JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (01) :31-40
[30]   Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease [J].
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3342-3344